FIELD: chemistry; biotechnology.
SUBSTANCE: invention relates to biochemistry. Described is a method of delivering a heterologous nucleic acid into a lung cell in a subject, involving administering to the subject a composition containing a recombinant adeno-associated virus (rAAV) vector. Said vector rAAV contains (i) a capsid containing a capsid protein containing an amino acid sequence presented as SEQ ID NO: 12, or an amino acid sequence at least 90% identical to SEQ ID NO: 12 and containing Thr at amino acid 469 and Ala at amino acid 598, based on amino acid numbering presented in SEQ ID NO: 12, and (ii) a heterologous nucleic acid containing a nucleotide sequence coding a gene product. Introduction includes pulmonary, endobronchial, intranasal, intratracheal and/or intrabronchial introduction. Described is a corresponding composition containing said vector. What is also described is a method of treating cystic fibrosis in a subject, involving administering said composition to the subject. Use of said composition in preparing a medicinal agent for treating cystic fibrosis, wherein the medicinal agent is intended for pulmonary, endobronchial, intranasal, intratracheal or intrabronchial administration.
EFFECT: invention extends the range of products for treating pulmonary diseases.
30 cl, 35 dwg, 18 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
NEW LIVER TARGETING ADENO-ASSOCIATED VIRAL VECTORS | 2019 |
|
RU2793735C2 |
METHODS FOR AAV DETECTION | 2017 |
|
RU2771622C2 |
TREATMENT OF COMPLEMENT-MEDIATED DISORDERS | 2017 |
|
RU2768982C2 |
GENOTHERAPY CONSTRUCTIONS FOR TREATMENT OF WILSON'S DISEASE | 2020 |
|
RU2807158C2 |
NEW CAPSID PROTEINS OF ADENO-ASSOCIATED VIRUS | 2017 |
|
RU2779318C2 |
GENE THERAPY FOR THE TREATMENT OF HEMOPHILIA A | 2017 |
|
RU2762257C2 |
ADENO-ASSOCIATED VIRAL VECTORS FOR TREATING MUCOLIPIDOSIS TYPE II | 2016 |
|
RU2742612C2 |
MODIFIED FACTOR IX, AS WELL AS COMPOSITIONS, METHODS AND OPTIONS FOR THE USE OF GENE TRANSFER INTO CELLS, ORGANS AND TISSUE | 2016 |
|
RU2811445C2 |
NUCLEIC ACID CONSTRUCTIONS AND VECTORS FOR GENOTHERAPY FOR TREATING WILSON'S DISEASE AND OTHER CONDITIONS | 2015 |
|
RU2745567C2 |
ISOLATED MODIFIED VP1 CAPSID PROTEIN OF ADENO-ASSOCIATED VIRUS OF SEROTYPE 5 (AAV5), CAPSID AND VECTOR BASED ON IT | 2019 |
|
RU2751592C2 |
Authors
Dates
2024-11-07—Published
2021-04-26—Filed